Zobrazeno 1 - 10
of 143
pro vyhledávání: '"Naota, Taura"'
Autor:
Ryu Sasaki, Naota Taura, Yasuhiko Nakao, Masanori Fukushima, Masafumi Haraguchi, Satoshi Miuma, Hisamitsu Miyaaki, Kazuhiko Nakao
Publikováno v:
Scientific Reports, Vol 13, Iss 1, Pp 1-7 (2023)
Abstract Impaired glucose tolerance, glucose fluctuations, and hypoglycemia have been observed in patients with chronic liver disease (CLD). The flash glucose monitoring (FGM) system, which recognises continuous and dynamic glucose changes in real ti
Externí odkaz:
https://doaj.org/article/2e9097a8073746a58a0456b9318c6067
Autor:
Takuya Kinoshita, Takehiro Matsumoto, Naota Taura, Tetsuya Usui, Nemu Matsuya, Mayumi Nishiguchi, Hozumi Horita, Kazuhiko Nakao
Publikováno v:
JMIR Formative Research, Vol 6, Iss 9, p e36525 (2022)
BackgroundRecently, the use of telehealth for patient treatment under the COVID-19 pandemic has gained interest around the world. As a result, many infodemiology and infoveillance studies using web-based sources such as Google Trends were reported, f
Externí odkaz:
https://doaj.org/article/c9bec31113384f7a885d70956d95d94e
Autor:
Ikuko Takahara, Yuko Akazawa, Maiko Tabuchi, Katsuya Matsuda, Hisamitsu Miyaaki, Youko Kido, Yasuko Kanda, Naota Taura, Ken Ohnita, Fuminao Takeshima, Yusuke Sakai, Susumu Eguchi, Masahiro Nakashima, Kazuhiko Nakao
Publikováno v:
PLoS ONE, Vol 15, Iss 7, p e0235729 (2020)
[This corrects the article DOI: 10.1371/journal.pone.0170591.].
Externí odkaz:
https://doaj.org/article/b1440c3d0dd44f18a1c7e888f535ac2f
Autor:
Takemasa Senoo, Ryu Sasaki, Yuko Akazawa, Tatsuki Ichikawa, Satoshi Miuma, Hisamitsu Miyaaki, Naota Taura, Kazuhiko Nakao
Publikováno v:
BMC Gastroenterology, Vol 18, Iss 1, Pp 1-9 (2018)
Abstract Background Geranylgeranylacetone (GGA), an anti-ulcer drug widely used in Japan, has attracted interest because of its various therapeutic effects. Therefore, we investigated the effects of GGA on human hepatic stellate cells (HSCs) in vitro
Externí odkaz:
https://doaj.org/article/4fee8fe4935d4e39abec2a734fa36c57
Autor:
KAZUYOSHI NAGATA, RYU SASAKI, SHINICHI IWATSU, MASANORI FUKUSHIMA, MASAFUMI HARAGUCHI, SHINOBU YAMAMICHI, SATOSHI MIUMA, HISAMITSU MIYAAKI, NAOTA TAURA, TAKUYA YAMAZAKI, KAZUHIKO NAKAO
Publikováno v:
Anticancer research. 42(10)
This study was conducted to determine the prognosis and risk factors for survival in patients treated with stereotactic body radiotherapy (SBRT) for hepatocellular carcinoma (HCC).This retrospective study analyzed 73 patients who underwent SBRT for H
Autor:
Ikuko Takahara, Yuko Akazawa, Maiko Tabuchi, Katsuya Matsuda, Hisamitsu Miyaaki, Youko Kido, Yasuko Kanda, Naota Taura, Ken Ohnita, Fuminao Takeshima, Yusuke Sakai, Susumu Eguchi, Masahiro Nakashima, Kazuhiko Nakao
Publikováno v:
PLoS ONE, Vol 12, Iss 3, p e0170591 (2017)
BACKGROUND AND AIMS:A high serum level of saturated free fatty acids (FFAs) is associated with the development of nonalcoholic fatty liver disease (NAFLD). X-box binding protein-1 (XBP-1) is activated by FFA treatment upon splicing. XBP-1 is a transc
Externí odkaz:
https://doaj.org/article/d2a6f12e86804872bb5eac169d4530d3
Autor:
Kazuhiko Nakao, Yasutaka Kuribayashi, Osamu Miyazaki, Mio Yamashima, Satoshi Miuma, Yasuhide Motoyoshi, Shinobu Yamamichi, Tatsuki Ichikawa, Keiji Kira, Ryouhei Uehara, Naota Taura, Hiroyuki Yajima, Yusuke Nakano, Hisamitsu Miyaaki, Makiko Koike, Tetsurou Honda
Publikováno v:
Internal Medicine
Objective Patient-reported outcomes (PROs) are important measures of the quality of life (QOL) and symptoms in patients with hepatitis C virus (HCV). We evaluated the PROs at the beginning of direct-acting antiviral (DAA) treatment and three years la
Autor:
Satoshi Miuma, Kazuhiko Nakao, Ryu Sasaki, Junya Miyamoto, Hidetaka Shibata, Shuntaro Sato, Hisamitsu Miyaaki, Masafumi Haraguchi, Naota Taura, Masanori Fukushima
Publikováno v:
Internal Medicine
Objective The influence of interferon (IFN)-free direct-acting antiviral (DAA) on hepatocellular carcinoma (HCC) recurrence remains unclear. Previous retrospective analyses revealed that the time interval between HCC curative treatment and IFN-free D
Autor:
Osamu Miyazaki, Naoyuki Hino, Tatsuki Ichikawa, Ryousuke Hirata, Tetsurou Honda, Mio Yamashima, Ryouhei Uehara, Kazuhiko Nakao, Satoshi Miuma, Hiroyuki Yajima, Naota Taura, Shinobu Yamamichi, Hisamitsu Miyaaki, Yasuhide Motoyoshi, Makiko Koike
Publikováno v:
Hepatology Research. 50:704-714
Aim Sarcopenia is a harmful condition in patients with chronic liver disease. However, the evaluation of body muscle mass requires expensive instrumentation. The sarcopenia index (SI): (creatinine / cystatin C × 100) has been reported to correlate w
Autor:
Tatsuki Ichikawa, Yasuhide Motoyoshi, Syouhei Narita, Youichi Takahashi, Naoyuki Hino, Tetsurou Honda, Ryousuke Hirata, Satoshi Miuma, Satomi Toda, Ryouhei Uehara, Kazuhiko Nakao, Tomoko Hori, Hiroyuki Yajima, Naota Taura, Hisamitsu Miyaaki
Publikováno v:
Internal Medicine
Objective Direct-acting antivirals (DAAs) for treating hepatitis C virus (HCV) infection exert a significantly high sustained viral response (SVR), and patients experience a rebound increase in low-density lipoprotein cholesterol (LDL) and total chol